Douglas W Kiburz, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 S Ingram Ave, Sedalia, MO 65301 Phone: 660-826-5890 |
Evan Ray Stout, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 S Ingram Ave, Sedalia, MO 65301 Phone: 660-826-5890 Fax: 660-826-4802 |
Dr. Brian K Ellefsen, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2100 W Main St, Sedalia, MO 65301 Phone: 660-826-5750 Fax: 660-829-5750 |
Ryan K Edwards, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 S Ingram Ave, Sedalia, MO 65301 Phone: 660-827-0505 Fax: 660-826-4802 |
News Archive
A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.
Using Chinese herbs either alone or in conjunction with chemotherapy may help protect a breast cancer patient's bone marrow and immune system, as well as improving the woman's overall quality of life.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
New technologies are emerging daily to help people plan, monitor, and enhance their health and fitness activities. Yet finding the ways and the time to stay fit and motivated can seem more complicated than ever before. Starting today, Best Buy customers in select markets from Washington, DC to Denver can turn to the nation's largest consumer electronics retailer for help in satisfying their health and fitness equipment and management needs.
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
› Verified 9 days ago